Abstract
Aim
This study aims to demonstrate the role of some inflammasomes genes: NLRC4 (the NLR family, CARD domain-containing protein 4), NLRP1 (NLR family, pyrin domain-containing 1), ASC (Apoptosis-associated speck-like protein containing a CARD), and CASPASE-1 in the pathogenesis of Rheumatoid arthritis (RA) in Egyptian population.
Main methods
The expression level of NLRC4, NLRP1, ASC, and CASPASE-1 within PBMCs isolated from all RA subjects by quantitative real-time PCR. GAPDH gene was used as a reference gene. Measurement of serum level of IL-1β and IL-18 was performed using ELISA.
Key findings
Results showed dysregulated inflammasomes expression that may participate in the pathogenesis of the inflammatory process of the disease.
Significance
Understanding the role of inflammasomes in RA pathogenesis helps in finding promising therapy for the treatment and management of this disease.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Rheumatoid arthritis (RA) is a symmetric polyarticular arthritis that primarily affects the small diarthrodial joints of the hands and feet. Rheumatoid arthritis affects about 1% of the world's population [1, 2]. In addition to inflammation in the synovium, which is the joint lining, the aggressive front of tissue called pannus invades and destroys local articular structures [3, 4]. Unmanaged RA can lead to joint deterioration and impairment, as well as a lower quality of life and a higher mortality rate.
The diagnostic methods for detection include clinical evaluation, imaging, and laboratory tests. The extent of the inflammation and damage is confirmed by blood tests [5]. The detection of rheumatoid factor and/or anti-citrullinated protein antibodies, a raised C-reactive protein level, or an increased erythrocyte sedimentation rate in a patient with inflammatory arthritis confirms the diagnosis of RA [6]. Research in the area of inflammatory illnesses has begun to concentrate on inflammasomes [7].
Inflammasomes working at intracellular levels primarily promote the responses to inflammatory events [8]. Inflammasome is crucial component of the innate inflammatory response that is a cytoplasmic multiprotein complex that enables the removal of foreign pathogens or the identification of endogenous danger signals. Extreme or unusual activation of numerous diseases, including autoimmune disorders, neurological conditions, and malignancies, have been demonstrated to be influenced by inflammasomes [9]. Interleukin-1β (IL-1β) and IL-18 are the two main inflammatory cytokines that are produced by inflammasomes. Inflammasomes are classically formed by assembling three major components, an inflammasome threat sensor, an adaptor protein, and an effector enzyme [10]. An adapter protein, mostly the apoptosis-associated speck-like protein (ASC protein), and Caspase-1 make up inflammasomes. Sensor proteins of inflammasomes exhibit extraordinary variety, which enables the formation of specific complexes designed to detect different signals [11].
Inflammasomes can be categorized into “canonical inflammasomes,” such as nucleotide-oligomerization domain (NOD)–like receptors (NLR) and absent in melanoma 2 inflammasomes (AIM2) besides non-canonical inflammasomes like caspase-4, caspase-5, and caspase-11 [12]. The first discovered NLR family member to form an inflammasome complex was NLRP1 [13]. ASC is very vulnerable to caspases, which intensify inflammatory activity because they release macrophages and other inflammatory cytokines into the bloodstream and trigger immunological reactions when they interact with other molecules [14].
Inflammasome activity that is dysregulated in many inflammation-related disorders drives pathology in contrast to these beneficial roles. Inflammasomes have the ability to potently trigger host-protective responses to infection and pathology in a variety of serious human diseases. All protective and pathogenic actions of inflammasomes are supported by the process by which inflammatory caspases acquire protease activity within inflammasomes [15].
Dysfunctional inflammasomes are linked to the pathophysiology of joint diseases. Treatment and diagnosis of inflammasome-induced inflammatory illnesses like rheumatoid arthritis can be improved by understanding the process of inflammasome activation and how they contribute in physiological and pathological states [16, 17].
According to a study that looked at the gene expression level of inflammasomes in a total of 1278 RA patients. ASC, MEFV, NLRP3-FL, NLRP3-SL, and CASP1 gene expression were significantly higher compared with controls, whereas CARD8 was lower in the patients. Interleukin-18 and caspase-1 levels were markedly elevated in RA patients. This study is one of many studies that demonstrated the impact of dysfunctional inflammasomes on the pathogenesis of RA [18].
In this study, we focused on the study of gene expression of some inflammasomes genes in rheumatoid arthritis patients in Egyptian population to reveal the role of dysregulated inflammasomes in the pathogenesis of RA. In addition, the impact of genetic factor as one of the parameters that can influence the progress of the disease and the regulation of the inflammasomes was studied. Also, we studies the effect of RA medications on the expression level of inflammasomes and serum levels of IL-1β and IL-18 which are hallmarks of the inflammasome activation.
Materials and methods
Subjects
Sample from 77 subjects were included in the study. These samples were classified into three groups:
-
Group1 (treated cases): 37 RA patients (30–72 years) receiving treatment (2 males and 35 females).
-
Group2 (untreated cases): 15 RA patients (23–62 years) not receiving treatment (1 male and 14 female).
-
Group3 (control group): 25 healthy individuals (24–53 years; 7 males and 18 females).
Cases were selected according to The American College of Rheumatology's updated classification criteria for rheumatic illnesses [19]. All subjects were free of infectious and autoimmune disorders. All subjects signed the informed consent form prior to the start of experiment. The study was approved by the “Commission on the Ethics of Scientific Research,” Faculty of Pharmacy, Minia University (HV03/2020).
Sample processing
Seven milliliters of peripheral blood were collected from each subject in an ethylene diamine tetraacetic acid (EDTA) vial. Three milliliters of whole blood were used for RNA extraction [20], two milliliters were used for ESR detection, and the remaining two milliliters were used for serum isolation and cytokines, RF, and Anti-CCP detection.
PBMC isolation from whole blood
Three milliliters of whole blood were placed over Histopaque-1077 (Sigma-Aldrich, Darmstadt, Germany) in order to isolate peripheral blood mononuclear cells (PBMCs). Additionally, the layer containing PBMCs or NK cells was isolated washed twice with PBS (Phosphate buffered saline). Then, RNA was extracted from cell pellets [21].
RNA extraction and cDNA synthesis
Total RNA from WBC pellet was extracted by using TRI reagent (Sigma®, USA) according to manufacturer’s instructions and quantified by using Nanodrop (ND-1000). A 1000 ng of total RNA after quantification was subjected to cDNA synthesis using cDNA synthesis kit (RevertAid First Strand cDNA Synthesis Kit; Thermo Scientific) according to manufacturer’s protocol [20].
Real-time quantitative reverse transcription-polymerase chain reaction
Quantitative real-time PCR (Applied Biosystems StepOne™ Instrument-Singapore) was used to assess the gene expression levels of NLRC4, NLRP1, ASC, and CASPASE-1 in all subjects using gene-specific primers (Table 1). Expression of the GAPDH gene was used as a reference.
An initial stage of activation at 95 °C for 10 min was followed by 45 cycles of denaturation and annealing (95 °C for 10 s, 65 °C for 15 s, and 72 °C for 20 s). A melt curve appears at the end of the amplification phase. Analysis was done to determine the specificity of the created products [22]. The comparative ΔΔCt method was used for data analysis to achieve relative quantification (RQ), in which the amount of target RNA was normalized to an endogenous reference gene (GAPDH) and compared to a control.
Enzyme-linked immunosorbent assay
A sandwich enzyme-linked immunosorbent assay (ELISA) was used to assess the levels of IL-18 and IL-1β in human serum in accordance with the manufacturer's instructions (Bioassay technology laboratory -Cat. No E0143Hu) [26].
Detection of ESR, RF, anti-CCP
ESR, RF, and Anti-CCP detection were carried out according the manufacturer's instructions (Globe SCIENTIFIC INC. Sedi-Rate™), (BEACON, RHEUMATOID FACTOR LATEX TEST KIT, (R.A. TEST KIT) J79B), and (Serazym® Anti-CCP IgG), respectively.
Statistical analysis
Data entry and data analysis were done using SPSS version 22 (Statistical Package for Social Science). Data were presented as number, percentage, mean, standard deviation, median, and range. Chi-square test and Fisher Exact test were used to compare between qualitative variables. In case of parametric data, independent samples t test was used to compare quantitative variables between two groups and ANOVA test for more than two groups, while in case of non-parametric data, Mann–Whitney test was used to compare quantitative variables between two groups and Kruskal–Wallis Test for more than two groups. Spearman correlation was done to measure correlation between quantitative variables. P value considered statistically significant when p < 0.05.
Results
Detection of rheumatoid factor (RF), erythrocyte sedimentation rate (ESR), and anti-cyclic citrullinated peptides (anti-CCP) in all subjects
RF was positive in 32 (86.5%) of treated cases and 10 (66.7%) of untreated cases without statistically significant difference between the two groups, while Anti-CCP was positive in 27 (73.0%) of treated cases and 11 (73.3%) of untreated cases without statistically significant difference between the two groups.
As shown in Table 2, ESR level was significantly higher in the untreated subjects compared with the treated cases. There was no significant difference in RF or Anti-CCP between the two groups.
Expression of NLRC4, NLRP1, ASC, and CASPASE-1 in PBMC of all subjects
The expression of NLRC4, NLRP1, ASC, and CASPASE-1 in the PBMC among the three groups was statistically significant (p value < 0.005), with the untreated RA group having lower expression level of NLRP1 and ASC than the treated and control groups. The expression level of caspase-1 and NLRC4 was significantly higher in the untreated cases compared to treated and healthy control groups. Table 3 shows these results.
Serum IL-18 and IL-1β levels
As shown in Table 4, serum levels of both IL-18 and IL-1β in treated subjects were significantly higher (p value < 0.005) compared with the treated group.
Correlation between the expression of CASPASE-1, NLRC4, NLRP1, and ASC inflammasomes genes
Analysis of the data revealed that there is no meaningful relationship between the expression of the genes for the inflammasomes caspase-1, NLRC4, NLRP1, and ASC among various groups of subjects (p value > 0.05). However generally, there was negative correlation between caspase-1 and ASC (r = -0.330, p = 0.017*).
Correlation between the expression of CASPASE-1, NLRC4, NLRP1, and ASC inflammasomes genes in relation to serum level of IL-18 and IL-1β
There was no statistically significant correlation between the expression of the genes for the inflammasomes caspase-1, NLRC4, NLRP1, and ASC and serum levels of IL-18 and IL-1β among various groups of subjects (p value > 0.05). However generally, there was positive correlation between the expression level of NLRC4 and IL-1β serum level (r = value; p = 0.286, p value = 0.040*).
Correlation between the expression of caspase-1, NLRC4, NLRP1, and ASC inflammasomes genes to RF titre, anti-CCP titre, ESR in group 1 & 2 (RA cases)
The expression of the genes for the inflammasomes caspase-1, NLRC4, NLRP1, and ASC did not significantly correlate with either RF titre in the treated or untreated groups (p value > 0.05). There was a positive correlation between NLRP1 expression level and Anti-CCP titre in the treated group (r value = 0.409, p value = 0.034*). In addition, a negative correlation between NLRC4 expression level and Anti-CCP in the untreated group was observed (r value = − 0.945, P value = 0.000*).
Note: The relationship r gauges how strongly two quantitative variables are correlated linearly. Pearson: The constant value of r is an integer between − 1 and 1. r > 0 denotes a positive connection. r > 0 denotes a negative association.
Discussion
The current work was initiated to study the involvement of certain inflammasome genes in the pathophysiology of RA in Egyptian patients. In this study, the Rheumatoid arthritis cases were more common in female where 94.6% of treated cases, and 93.3% of untreated cases were females. This is consistent with a previous study reporting a woman-to-man ratio of 1:3 [27]. This distinction is crucial since, in recent decades, gender has attracted much study as a predictor of RA prognosis [28].
In our study, ESR level was significantly higher in the untreated subjects compared with the treated cases. There was no significant difference in RF or Anti-CCP between the two groups.
RA clinical trial inclusion criteria frequently include an ESR of more than 28 mm/h as shown from ESR levels in treated cases and in untreated cases.
Cytokines such as interleukin (IL)-1β and IL-18 are important in autoimmune and inflammatory human diseases. Both cytokines utilize common signal transduction cascades to drive a variety of pro-inflammatory effector networks in various cell types. In tissue and fluid samples isolated from individuals with numerous chronic inflammatory illnesses, IL-1β, IL-18, and other members of the IL-1 superfamily are expressed at high levels [29].The present study showed that the level of serum IL-1β and IL-18 in untreated RA cases was higher compared with treated RA cases and healthy control groups. These results are consistent with a study performed on circulating cytokine levels in patients with rheumatoid arthritis [30] who demonstrated that, if these cytokines are present in measurable amounts prior to treatment, successful treatment with the disease-modifying medication such as sulphasalazine will lead to a reduction in serum levels of IL-lα, IL-1β, and TNF-α.
Inflammasomes play a key role in controlling inflammation. If their expression is dysregulated, they will lead to a number of diseases. Epigenetic pathways are known to be involved in the regulation of inflammasome expression, according to a recent study [31].
In our study, we focused on gene expression of NLRP1, NLRC4, Caspase-1, and ASC inflammasomes to determine whether these inflammasomes included in the pathogenesis of RA through detection of the expression level of them in RA patients and healthy controls as well as to clarify the effect of treatment on their expression through detection of their expression level in treated and untreated cases.
Our findings showed that, the expression levels of NLRP1and ASC inflammasome genes were significantly lower in untreated RA cases compared to treated RA cases and healthy control group. These results are in agreement with previous study made by Wang and his colleagues, and they demonstrated that the expression levels of NLRP1mRNA in PBMC in RA patients were considerably lower than those in the normal control group, indicating that NLRP1 inflammasomes signaling pathways is connected with RA susceptibility [19]. One theory is that there may be an NLRP1 negative regulatory factor that is downregulated in RA inflammatory responses and that inhibits NLRP1 assembly and caspase-1 activation through the NLRP1-signaling pathway [19].
Another interesting finding is that the expression levels of Caspase-1and NLRC4 were higher in untreated cases than treated and control groups. This result supports recently released data that comparing RA patients to healthy controls, caspase-1 was considerably activated. As a protease, caspase-1 catalyzes its substrates to produce biological effects. There are lesser-known pro-IL-1β and pro-IL-18 [32].
Findings of the study proved that there was a statistically significant difference in the expression levels of Caspase-1, NLRP1, and ASC inflammasome genes between the treated group and untreated group. On the other hand, there is no statistically significant difference in the expression level of NLRC4 inflammasome gene. There was a statistically significant difference in the expression levels of Caspase-1, NLRC4, NLRP1, and ASC inflammasomes between untreated RA and healthy control groups while. There was no significant difference between treated RA group and healthy control group in the expression of Caspase-1, NLRP1, and ASC inflammasome genes, but there was a statistically significant difference in the expression level of NLRC4 inflammasome gene.
A study performed by Noroozi and others on the Impact of IFN-β1α treatment on the expression of NLRP3, NLRP1, NLRC4, and AIM2 inflammasomes, as well as caspase-1, IL-1β, and IL-18 as the inflammasomes' downstream molecules; the study revealed that IFN-β1aα modified several inflammasomes' mRNA expression, including NLRP3, NLRC4, and AIM2 (but not NLRP1). Patients receiving IFN-β1α treatment had considerably lower plasma levels of IL-1β [33]. This may explain the change in the level of the expression of inflammasomes in patients received regimen. Addobbati and his assistants mentioned the absence of statistically significant difference between gene expression levels of patients with the disease in remission and patients with high disease activity. Previous finding proved that while the treatment of patients is effective in controlling the disease symptoms, it may not be able to control the deregulation of inflammasome [34].
When we applied correlation, we discovered that the expression of the inflammasome genes caspase-1, NLRC4, NLRP1, and ASC did not significantly correlate across different subject populations. Overall, there was a negative correlation between caspase-1 and ASC.
It was observed that generally, there was no statistically significant relationship between blood levels of IL-18 and IL-1 and the expression of the genes for the inflammasomes caspase-1, NLRC4, NLRP1, and ASC, among different subject groups, while there was positive correlation between the expression level of NLRC4 and IL-1β serum level.
However, there was a positive correlation between NLRP1 expression level and Anti-CCP titre in the treated group and a negative correlation between NLRC4 expression level and Anti-CCP in the untreated group. The expression of the genes for the inflammasomes caspase-1, NLRC4, NLRP1, and ASC did not significantly correlate with either RF titre in the treated or untreated groups.
There was a study done by Yang and his colleagues revealed that activated caspase-1 protein level and serum IL-18 level showed a strong positive connection. However, there was no connection between the level of serum IL-1β and activated caspase-1 protein [35].
Additionally, a study made in China by Wang and others concluded that NLRP1 mRNA expression level showed a negative link with anti-RF antibody that is not consistent with these results, and also showed that ASC, caspase-1 mRNA expression level had no correlation with RF in the RA group that supports our results [19].
Therefore, in addition to the increased level of serum IL-18 and IL-1β, the deregulated activation of these inflammasomes may exacerbate the cell death, contributing to the inflammatory process and its maintenance in RA disease.
Conclusion and future prospects
The study revealed the role of inflammasomes in the pathogenesis of rheumatoid arthritis which can represent a promising therapeutic target for treating the inflammation in these patients. Our future plan will try to find association between these inflammasomes genes and other common human diseases among Egyptians as cancer, hypertension, type 2 diabetes, and other autoinflammatory diseases.
Data availability
The corresponding author can provide the datasets used in and/or analyzed during the current work upon justifiable request.
References
Pisetsky DS (2017) Advances in the treatment of rheumatoid arthritis: costs and challenges. North Carolina Med J 78(5):337–340
Croia C et al (2019) One year in review 2019: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 37(3):347–357
Moreland LW et al (1997) Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)–Fc fusion protein. New Engl J Med 337(3):141–147
Lipsky PE et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. New Engl J Med 343(22):1594–1602
Alippe Y, Mbalaviele G (2019) Omnipresence of inflammasome activities in inflammatory bone diseases. Seminars in immunopathology. Springer, Berlin
Wasserman A (2018) Rheumatoid arthritis: common questions about diagnosis and management. Am Family Phys 97(7):455–462
Yin H et al (2022) Role of NLRP3 inflammasome in rheumatoid arthritis. Front Immunol 13:931690
Dong X et al (2020) ACPAs promote IL-1β production in rheumatoid arthritis by activating the NLRP3 inflammasome. Cell Mol Immunol 17(3):261–271
Jiang Q et al (2022) Inflammasome and its therapeutic targeting in rheumatoid arthritis. Front Immunol 12:816839
Nandi D et al (2022) Imaging approaches to monitor inflammasome activation. J Mol Biol 434(4):167251
Latz E, Xiao TS, Stutz A (2013) Activation and regulation of the inflammasomes. J Nat Rev Immunol 13(6):397–411
Kastbom A, Ärlestig L, Rantapää-Dahlqvist S (2015) Genetic variants of the NLRP3 inflammasome are associated with stroke in patients with rheumatoid arthritis. J Rheumatol 42(10):1740–1745
Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. J Mol cell 10(2):417–426
Arnoult D et al (2009) An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix. J Cell Sci 122(17):3161–3168
Ross C et al (2022) Inflammatory caspases: toward a unified model for caspase activation by inflammasomes. Annu Rev Immunol 40:249–269
Booshehri LM, Hoffman HM (2019) Caps and NLRP3. J Clin Immunol 39:277–286
Swanson KV, Deng M, Ting JP-Y (2019) The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol 19(8):477–489
Mathews RJ et al (2014) Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Ann Rheum Dis 73(6):1202–1210
Wang T et al (2014) Role of NLRP3 and NLRP1 inflammasomes signaling pathways in pathogenesis of rheumatoid arthritis. Asian Pac J Trop Med 7(10):827–831
Verma V et al (2019) Involvement of NLRP3 and NLRC4 inflammasome in uropathogenic E coli mediated urinary tract infections. Front Microbiol 10:2020
Elemam NM et al (2020) Differentially expressed genes of natural killer cells can distinguish rheumatoid arthritis patients from healthy controls. Genes 11(5):492
Dwivedi M et al (2013) Association of NLRP 1 genetic variants and m RNA overexpression with generalized vitiligo and disease activity in a G ujarat population. Br J Dermatol 169(5):1114–1125
Zhang A et al (2015) Mechanisms that lead to the regulation of NLRP3 inflammasome expression and activation in human dental pulp fibroblasts. Mol Immunol 66(2):253–262
Verma V et al (2019) Involvement of NLRP3 and NLRC4 inflammasome in uropathogenic E. coli mediated urinary tract infections. Front Microbiol 10:2020
Dwivedi M et al (2013) Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population. Br J Dermatol 169(5):1114–1125
Yin X et al (2016) Increased expression of the NOD-like receptor family, pyrin domain containing 3 inflammasome in dermatomyositis and polymyositis is a potential contributor to their pathogenesis. Chin Med J 129(09):1047–1052
Myasoedova E et al (2010) Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955–2007. Arthritis Rheumatism 62(6):1576–1582
Tengstrand B, Ahlmén M, Hafström I (2004) The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years. J Rheumatol 31(2):214–222
Braddock M, Quinn A, Canvin J (2004) Therapeutic potential of targeting IL-1 and IL-18 in inflammation. Expert Opin Biol Ther 4(6):847–860
Danis V et al (1992) Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine. Ann Rheumatic Dis 51(8):946–950
Poli G et al (2020) Epigenetic mechanisms of inflammasome regulation. Int J Mol Sci 21(16):5758
Denes A, Lopez-Castejon G, Brough DJ (2012) Caspase-1: is IL-1 just the tip of the ICEberg? Cell Death Dis 3(7):e338–e338
Noroozi S et al (2017) The effects of IFN-β 1a on the expression of inflammasomes and apoptosis-associated speck-like proteins in multiple sclerosis patients. Mol Neurobiol 54(4):3031–3037
Addobbati C et al (2018) Polymorphisms and expression of inflammasome genes are associated with the development and severity of rheumatoid arthritis in Brazilian patients. Inflamm Res 67:255–264
Yang Z et al (2016) Caspase-1 mediated interleukin-18 activation in neutrophils promotes the activity of rheumatoid arthritis in a NLRP3 inflammasome independent manner. Joint Bone Spine 83(3):282–289
Acknowledgements
Not applicable
Funding
Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). No funding has been received for this manuscript.
Author information
Authors and Affiliations
Contributions
RI, MAR, MMA, NSA, and NGFMW each contributed to the laboratory analysis and interpretation of the data, and revised the manuscript for important scientific content. EMAf contributed to the clinical samples supply. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing interests.
Ethical approval
“The commission on the Ethics of scientific research,” Faculty of pharmacy, Minia university has been approved this research project. Code number of the project: HV03/2020. Each participant signed a written, informed consent form. Every procedure was carried out in accordance with the values outlined in the Helsinki Declaration.
Consent for publication
Written and informed consent for publication was obtained from all patients. Patients were informed that de-identified data would be used in the scientific research and publications.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ibrahem, R., Raghip, M.A., Abdelwahed, M.M. et al. Role of some inflammasomes in rheumatoid arthritis patients in Egypt. Mol Biol Rep 50, 8809–8815 (2023). https://doi.org/10.1007/s11033-023-08738-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-023-08738-1